Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian Cancer.

Current oncology (Toronto, Ont.)·2026
Same author

Atezolizumab does not improve progression-free survival in patients with recurrent platinum-sensitive ovarian cancer.

Gynecology and pelvic medicine·2026
Same author

Applying the health belief model to explore healthcare provider and patient perspectives on homologous recombination deficiency testing in cancer: A narrative review.

Cancer treatment and research communications·2026
Same author

Pre-operative positron emission tomography scan is associated with lower rates of adjuvant treatment in surgically treated patients with cervical cancer: a 4C Working Group study.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Randomized Controlled Trial of the Meaning-Making Intervention (MMi) in Patients Newly Diagnosed With Advanced Cancer: Full Trial.

Psycho-oncology·2026
Same author

Recurrence Patterns After Complete Cytoreduction for Advanced Ovarian Cancer: Robotic Versus Open Surgery.

Current oncology (Toronto, Ont.)·2026

Related Experiment Video

Updated: Jun 27, 2025

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.1K

Association between BMI and oncologic outcomes in epithelial ovarian cancer: a predictors-matched case-control study.

Gabriel Levin1, Yoav Brezinov2, Yossi Tzur2

  • 1Division of Gynecologic Oncology, Jewish General Hospital, McGill University, Montreal, QC, Canada. gabriel.levin2@mail.mcgill.ca.

Archives of Gynecology and Obstetrics
|May 7, 2024
PubMed
Summary
This summary is machine-generated.

Obesity in ovarian cancer patients did not significantly impact overall survival, despite an initial apparent improvement in 3-year survival. Further research is needed to understand the long-term effects of obesity on ovarian cancer outcomes.

Keywords:
Case-controlMatchedObesityOvarian cancerSurvival

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.7K
Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

2.6K

Related Experiment Videos

Last Updated: Jun 27, 2025

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.1K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.7K
Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

2.6K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Epidemiology

Background:

  • Obesity is a growing global health concern.
  • Its impact on cancer patient survival, particularly in ovarian cancer, requires thorough investigation.
  • Understanding these associations helps in personalized treatment strategies.

Purpose of the Study:

  • To investigate the association between obesity and survival in ovarian cancer patients.
  • To account for confounding factors such as disease stage, histology, and comorbidities.
  • To compare outcomes between obese and non-obese ovarian cancer patients.

Main Methods:

  • A retrospective matched case-control study was conducted.
  • Obese patients (BMI ≥ 35 kg/m²) were matched 1:4 with non-obese patients (BMI < 35 kg/m²).
  • Matching criteria included disease stage, cytoreduction status, tumor histology, and ASA score. Survival analyses used Kaplan-Meier curves and Cox proportional hazards models.

Main Results:

  • The study included 153 ovarian cancer patients (32 obese, 121 non-obese).
  • Obese and non-obese groups showed similar recurrence rates and overall mortality.
  • While 3-year overall survival was higher in the obese group, this difference diminished over time. Neoadjuvant treatment independently predicted longer overall and recurrence-free survival.

Conclusions:

  • Obesity does not appear to be significantly associated with long-term survival in ovarian cancer patients.
  • An initial observation of improved 3-year survival in obese patients was not sustained.
  • Neoadjuvant treatment emerged as a significant independent predictor of better outcomes.